In line with previous studies, anti-NXP2 antibodies were significantly associated with DMSD; Inoue et al. found that 86% of DMSD patients were positive for anti-NXP2 [26]. This evidence concerns the gene MORC3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.